51905-70-5Relevant academic research and scientific papers
Inhibition of patched drug efflux increases vemurafenib effectiveness against resistant brafv600e melanoma
Azoulay, Stéphane,Bertolotto, Corine,Biou, Valérie,Bretillon, Lionel,Debayle, Delphine,Di Giorgio, Audrey,Douguet, Dominique,Duca, Maria,Elizarov, Nelli,Girard, Christophe,Labbal, Fabien,Mus-Veteau, Isabelle,Paquet, Agnès,Signetti, Laurie,Simsir, Méliné,Verrier, Bernard
, p. 1 - 28 (2020)
Melanoma patients harboring the BRAFV600E mutation are treated with vemurafenib. Almost all of them ultimately acquire resistance, leading to disease progression. Here, we find that a small molecule from a marine sponge, panicein A hydroquinone
